Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study.

Source:http://linkedlifedata.com/resource/pubmed/id/15199077

Download in:

View as

General Info

PMID
15199077